Pipeline
Nymox is developing novel, safe and proprietary treatments targeting large markets and expanding markets in a rapidly aging population. Nymox’ unique, advanced product candidates address significant unmet medical needs for better treatment options in the indications they are being developed for.
Press releases
March 21, 2023
Nymox Announces Appointment of Christopher R. Riley as Chief Financial Officer